Anika Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Cash & Equivalents	72.87	86.33	94.39	95.82	157.46	89.04	133.26	104.26	110.71	100.16	Upgrade
Short-Term Investments	0	0	0	2.5	27.48	69.97	24	20.5	27.75	6.75	Upgrade
Cash & Cash Equivalents	72.87	86.33	94.39	98.32	184.94	159.01	157.26	124.76	138.46	106.91	Upgrade
Cash Growth	-15.59%	-8.54%	-4.00%	-46.84%	16.31%	1.12%	26.05%	-9.89%	29.51%	68.80%	Upgrade
Receivables	35.96	34.63	29.84	24.1	23.08	20.78	23.83	27.6	21.65	17.15	Upgrade
Inventory	46.39	39.77	36.01	46.21	22	21.3	22.04	15.98	14.94	12.41	Upgrade
Other Current Assets	8.1	8.83	8.29	8.75	4.29	1.85	3.21	2.1	1.39	1.37	Upgrade
Total Current Assets	163.31	169.55	168.53	177.38	234.31	202.94	206.33	170.44	176.43	137.84	Upgrade
Property, Plant & Equipment	74.97	78.98	68.56	73.23	73.65	54.11	56.18	52.3	40.11	31.67	Upgrade
Goodwill and Intangibles	12.2	81.94	90.16	99.57	15.28	17.04	18.85	17.44	19.14	23.23	Upgrade
Other Long-Term Assets	20.16	18.67	20.29	15.42	7.48	4.9	1.25	0.07	0.07	0.07	Upgrade
Total Long-Term Assets	107.32	179.58	179.01	188.22	96.4	76.05	76.29	69.81	59.32	54.97	Upgrade
Total Assets	270.63	349.13	347.54	365.61	330.71	278.99	282.62	240.25	235.75	192.81	Upgrade
Accounts Payable	9.86	9.07	7.63	8.98	3.83	3.14	6.75	2.3	8.3	1.2	Upgrade
Deferred Revenue	0	0	0	0	0	0	0	0	0.07	0.1	Upgrade
Other Current Liabilities	21.2	18.84	22.16	27.88	12.45	8.15	6.33	6.5	8.91	4.67	Upgrade
Total Current Liabilities	31.06	27.91	29.8	36.87	16.28	11.29	13.07	8.8	17.28	5.97	Upgrade
Long-Term Debt	26.9	28.82	19.24	20.88	21.37	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0.4	6.83	11.42	35.46	4.69	4.09	6.05	8.67	7.62	8.74	Upgrade
Total Long-Term Liabilities	27.31	35.65	30.66	56.34	26.06	4.09	6.05	8.67	7.62	8.74	Upgrade
Total Liabilities	58.37	63.57	60.45	93.21	42.33	15.38	19.13	17.47	24.9	14.71	Upgrade
Total Debt	26.9	28.82	19.24	20.88	21.37	0	0	0	0	0	Upgrade
Debt Growth	-6.64%	49.78%	-7.85%	-2.28%	-	-	-	-	-	-	Upgrade
Retained Earnings	128.05	210.72	225.58	221.44	245.43	218.23	199.51	168.21	135.66	104.9	Upgrade
Comprehensive Income	-5.94	-6.44	-5.72	-4.54	-5.9	-5.53	-4.78	-7.32	-6.65	-4.5	Upgrade
Shareholders' Equity	212.27	285.56	287.09	272.4	288.38	263.61	263.49	222.77	210.85	178.1	Upgrade
Net Cash / Debt	45.96	57.51	75.15	77.44	163.58	159.01	157.26	124.76	138.46	106.91	Upgrade
Net Cash / Debt Growth	-20.08%	-23.47%	-2.96%	-52.66%	2.87%	1.12%	26.05%	-9.89%	29.51%	68.80%	Upgrade
Net Cash Per Share	3.14	3.95	5.14	5.45	11.38	10.83	10.44	8.25	9.04	7.00	Upgrade
Working Capital	132.25	141.63	138.73	140.52	218.03	191.65	193.25	161.64	159.16	131.86	Upgrade
Book Value Per Share	14.48	19.61	19.93	19.15	20.42	18.25	18.08	15.17	14.12	12.13	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).